New Non-Steroid eye shot could ease blurry vision
NCT ID NCT06825702
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new eye injection called KIO-104 for people with macular edema, a condition where fluid builds up in the eye and blurs vision. About 28 adults will receive multiple doses to see if the drug is safe and helps reduce swelling. The goal is to find a steroid-free option for treating this eye problem.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- KIO-104 (a non-steroidal eye injection)
- What this could lead to
- If successful, this could lead to a new treatment option for macular edema that avoids steroids and their side effects.
- What could go wrong
- This is an early Phase 2 trial with only 28 participants, so results may not apply to everyone. The drug is still being tested for safety and may not improve vision.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Centre for Eye Research Australia
RECRUITINGEast Melbourne, Victoria, 3002, Australia
-
Hobart Eye Surgeons
RECRUITINGHobart, Tasmania, 7000, Australia
-
Lions Eye Institute Limited
RECRUITINGNedlands, Western Australia, 6009, Australia
Contact Email: •••••@•••••
-
Royal Adelaide Hospital
NOT_YET_RECRUITINGAdelaide, South Australia, 5000, Australia
-
Sydney Eye Hospital
RECRUITINGSydney, New South Wales, 2001, Australia
-
Sydney West Retina
NOT_YET_RECRUITINGWestmead, New South Wales, 2145, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New eye drug aims to restore vision in Diabetes-Related swelling
- New eye drug aims to restore vision in Diabetes-Related swelling
- Lockdown diaries: 1,300 patients reveal hidden health risks
- Higher-Dose eye injection may cut treatment visits for Vein-Related vision loss
- Super-Scope for eyes: imaging trial spots hidden clues in blindness
- New eye camera could diagnose problems in seconds